Get the L Out originally printed a list of side effects that were made up, back in their early days, to try and scare people into not seeking any medication.
I’d like to see this - I can compare to the official drug information and subsequent reporting. Do you have the list?
The list of side effects for all GnRH class drugs is long, and unpleasant. There’s no need to make anything up to scare people - the existing side effect list is bad enough.
The FDA is currently investigating 10,000 yellow card / adverse event reports on Lupron - considering the size of the treated population that’s a very big deal.
These are not benign drugs. They are powerful, and have multisystemic, often irreversible effects. They should not be being used on children (except under exceptionally rare circumstances for central precocious puberty for example) AT ALL.
So we are in the situation where we wonder why adults would want to demedicalise adult treatment, leaving them sexually intact, but push treatment on minors that will leave them infertile, with minimal sexual function in later life. From an ethics point of view, that’s all the red flags. All of them. Waving in unison.
The way children are ‘marketed’ to directly over the Internet is of deep concern too. There are websites, you tube influencers and adult lobby groups telling children to access these drugs and showing them how.
Some lobby groups advocate confidential disclosure - that means that for example they encourage a teacher to keep quiet if a child disclosed to them that they are having issues with gender. Why is that a problem? Well it goes against all the safeguarding regulations we have - it’s been called an abusers charter before.
The way children are being targeted over puberty blockers is deeply worrying. Direct pushing via the web, coaching to say ‘the right things’ to access drugs, incorrect information given to parents and children - that these drugs are a harmless pause button etc and reversible.
It all adds up to a rather murky, unethical situation. To put it mildly.